Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
G patch domain-containing protein 2-like (GPATCH2L) is a human protein encoded by the GPATCH2L gene located at chromosome 14q24.3[1][5]. The protein contains a characteristic G-patch domain, and is predicted to function in RNA metabolism, likely contributing to RNA processing within nuclear compartments such as the nucleolus[2][4][1]. Experimental evidence shows GPATCH2L interacts with proteins involved in ribosome biogenesis and RNA processing (e.g., KRR1, DDX10, NOL6)[1]. Expression is highest in bone marrow, testis, and brain, with protein predominantly localized in the nucleus[1][8]. Disease associations include various cancers (e.g., breast, pancreatic, maxillary, and jaw), and genetic variation in the GPATCH2L locus is linked to scleroderma renal crisis and Retinitis pigmentosa 24[5][1]. While involvement in disease is noted, there are no known drugs directly targeting GPATCH2L, nor is it considered a standard therapeutic target or biomarker at this time[1][5]. The precise biological function of GPATCH2L remains incompletely understood[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on G patch domain-containing protein 2-like (GPATCH2L).